The title polyanion is the first hybrid borophosphate-phenylphosphonate polyoxometalate. It was structurally characterized as its imidazolium salt, (C(3)N(2)H(5))(5)[Mo(12)O(30)(BPO(4))(2)(O(3)P-Ph)(6)].H(2)O (monoclinic, P2(1)/c, a = 22.120(3) A, b = 13.042(2) A, and c = 32.632(4) A, beta = 101.293(3) degrees ), which was synthesized hydrothermally from imidazole, molybdenum oxide and metal, and boric, phosphoric, and phenylphosphonic acids. The anion is the second example of a new class of polyoxometalates that resemble Dawson anions but where the two pole caps of three edge-sharing MoO(6) octahedra in the latter are replaced by other units, in this case tetrahedral borate sharing corners with three phenylphosphonic groups, [(OB)(O(3)P-Ph)(3)]. The 12 molybdenum atoms forming the two equatorial belts of the cluster are of mixed-valence, five are Mo(V) and seven are Mo(VI), and the resulting five electrons are delocalized. Four of these electrons are paired according to the temperature dependence of the magnetic susceptibility. The new compound is soluble in a mixture of water and pyridine (in equal volumes) as well as in nitromethane, and the anions are intact in these solutions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/ic020635u | DOI Listing |
RSC Med Chem
September 2024
Laboratory of Organic and Medicinal Chemistry, Department of Chemistry, Central University of Punjab Bathinda Punjab India-151401 +911642864214.
Alzheimer's disease (AD) is a complex neurological disorder and multiple pathways are associated with its pathology. Currently available single-targeting drugs are found to be ineffective for the treatment of AD, and most of these drugs provide symptomatic relief. The multi-target directed ligand strategy is proposed as an effective approach for the treatment of AD.
View Article and Find Full Text PDFChem Biol Drug Des
September 2024
Atta-Ur-Rahman Institute for Natural Product Discovery, Universiti Teknologi MARA (UiTM), Bandar Puncak Alam, Selangor, Malaysia.
Diabetes Mellitus (DM) is linked to various factors causing cardiovascular diseases, with uncontrolled postprandial hyperglycemia being a direct contributor. α-Glucosidase inhibitors (AGIs) aid in reducing postprandial hyperglycemia, potentially mitigating cardiovascular risks. In order to synthesize novel chemical scaffolds with possible α-glucosidase inhibition activity, a series of novel soritin sulfonamide derivatives were synthesized.
View Article and Find Full Text PDFJ Med Chem
September 2024
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, People's Republic of China.
Small
November 2024
Guangdong Provincial Key Laboratory of New Energy Materials Service Safety, Shenzhen Key Laboratory of New Information Display and Storage Materials, College of Materials Science and Engineering, Shenzhen University, Shenzhen, 518060, China.
The advancement of acceptors plays a pivotal role in determining photovoltaic performance. While previous efforts have focused on optimizing acceptor-donor-acceptor-donor-acceptor (A-DA-D-A)-typed acceptors by adjusting side chains, end groups, and conjugated extension of the electron-deficient central A unit, the systematic exploration of the impact of peripheral aryl substitutions, particularly with different electron groups, on the A unit and its influence on device performance is still lacking. In this study, three novel acceptors - QxTh, QxPh, and QxPy - with distinct substitutions on the quinoxaline (Qx) are designed and synthesized.
View Article and Find Full Text PDFChem Sci
July 2024
Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University Katsura, Nishikyo-ku Kyoto 615-8510 Japan
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!